Gynecologic Oncologist: Ronald K. Potkul, MD | Loyola Medicine

Ronald K. Potkul, MD, FACS,FACOG

Ronald K. Potkul, MD, FACS,FACOG

Obstetrics and Gynecology

Gynecologic Oncology
Professor
Department Chairperson, Obstetrics and Gynecology

Languages Spoken

English

Clinical Expertise

About Dr. Potkul

Interests
Basketball, Scuba Diving, Skiing, Sailing, Family Time, Wine and Food

Medical Education

Medical School
University of Chicago Pritzker School of Medicine
Residency
University of Chicago Hospitals and Clinics - Obstetrics & Gynecology
Fellowship
  • Georgetown University Medical Center - Obstetrics & Gynecology: Gynecological Oncology

Board Certification

American Board of Obstetrics & Gynecology
American Board of Obstetrics & Gynecology Subspecialty Gynecologic Oncology

Research

  • Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Kharouta, MZ; Pham, N; Nieto, K; Surucu, M; Mysz, ML; Albuquerque, K; Winder, A; Liotta, M; Potkul, RK; Small, W; Harkenrider, MM, Brachytherapy
  • Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients? Nieto, K; Martin, B; Pham, N; Palmere, L; Silva, SR; Winder, A; Liotta, M; Potkul, RK; Small, W; Harkenrider, MM, Brachytherapy
  • Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W. Jr, Brachytherapy
View All ResearchShow Less
  • Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, ML; Mehrotra, S; Aldulescu, M; Potkul, RK; Liu, Y; Grisoli, A; Joyce, C; O'Brien, TE; Stack, MS; Stiff, PJ, Journal of ovarian research
  • Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study Albuquerque, K.; Folkert, M.; Mayadev, J.; Christie, A.; Liotta, M. R.; Nagel, C.; Sevak, P.; Harkenrider, M. M.; Lea, J. S.; Hanna, R. K.; Small, W. C., Jr; Miller, D. S.; Xie, X. J.; Potkul, R. K.; Elshaikh, M. A., American Journal of Clinical Oncology
  • Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W., Jr, Brachytherapy
  • How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer Harkenrider, M. M.; Shea, S. M.; Wood, A. M.; Chinsky, B.; Bajaj, A.; Mysz, M.; Yacoub, J. H.; Goldberg, A.; Liotta, M.; Potkul, R.; Surucu, M.; Roeske, J.; Small, W., Jr, Journal of contemporary brachytherapy
  • Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer. Albuquerque, K; Patel, M; Liotta, M; Harkenrider, M; Guo, R; Small, W; Ronald, P, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S., NPJ breast cancer
  • Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman Bahar, B.; Hu, Z.; Szpaderska, A.; Liotta, M.; Potkul, R. K.; Smith, D.; Ersahin, C., International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Albuquerque, K.; Giangreco, D.; Morrison, C.; Siddiqui, M.; Sinacore, J.; Potkul, R.; Roeske, J., International journal of radiation oncology, biology, physics
  • Hepatic resection for recurrent metastatic ovarian cancer. Abood, G.; Bowen, M.; Potkul, R.; Aranha, G.; Shoup, M., American Journal of Surgery
  • FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast. Omeroglu, G.; Ersahin, C.; Potkul, R. K.; Booth, C. N., Diagnostic cytopathology
  • Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia. Ersahin, C.; Omeroglu, G.; Potkul, R. K.; Salhadar, A., Gynecologic oncology
  • Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B., Gynecologic oncology
  • Mesonephric adenocarcinoma of the vagina with a 3-year follow-up. Ersahin, C.; Huang, M.; Potkul, R. K.; Hammadeh, R.; Salhadar, A., Gynecologic oncology
  • Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes Contreras, D. N.; Krammer, P. H.; Potkul, R. K.; Bu, P.; Rossi, J. L.; Kaufmann, A. M.; Gissmann, L.; Qiao, L., Journal of immunotherapy (Hagerstown, Md.: 1997)